(Q51374652)

English

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation.

scientific article published on 27 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

Santiago Montes-Moreno

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Julio Diaz-perez

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

16

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Miguel A. Piris

20

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Magdalena Adrados

object named as

Magdalena Adrados

14

0 references

19

object named as

Ken H Young

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Manuela Mollejo

11

object named as

Manuela Mollejo

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Francisca Camacho-Morell

12

object named as

Francisca I Camacho

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Raquel M Pajares

9

object named as

Raquel Pajares

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

2

object named as

Lina Odqvist

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Sonia Gonzalez de Villambrosía

5

object named as

Sonia Gonzalez de Villambrosía

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Francisco Mazorra

6

object named as

Francisco Mazorra

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

author name string

Ana Batlle Lopez

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Maria E Castillo

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Mar Lopez

8

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Juan F García

10

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Carmen Ruiz-Marcellán

13

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Nazario Ortiz

15

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Carlos Ortiz-Hidalgo

17

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Ana Suarez-Gauthier

18

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

publication date

27 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

25

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

968-982

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

https://scigraph.springernature.com/pub.10.1038/modpathol.2012.52

0 references

Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Tissue microarray technology for high-throughput molecular profiling of cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Presence of monoclonal T-cell populations in B-cell post-transplant lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Lymphoid tissues from patients with infectious mononucleosis lack monoclonal B and T cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Prognostic biomarkers in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Oncogenic activation of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

B cells under influence: transformation of B cells by Epstein–Barr virus

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Genome wide DNA-profiling of HIV-related B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Genomic imbalances in AIDS-related lymphomas: relation with tumoral Epstein-Barr virus status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

21 January 2018

Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced sensitivity with a novel TCRgamma PCR assay for clonality studies in 569 formalin-fixed, paraffin-embedded (FFPE) cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

7 January 2021

based on heuristic

inferred from DOI database lookup

LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.52

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2012.52

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/22538516

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51374652&oldid=1835166723"